Deset let Državnega presejalnega programa za raka dojk DORA
Ten years of the National breast cancer screening programme DORA

  • Katja Jarm Institute of Oncology Ljubljana
  • Kristijana Hertl Institute of Oncology Ljubljana
  • Mateja Krajc Institute of Oncology Ljubljana
  • Cveto Šval Institute of Oncology Ljubljana
  • Veronka Kutnar Institute of Oncology Ljubljana
  • Mateja Kurir Institute of Oncology Ljubljana
  • Maja Primic Žakelj Institute of Oncology Ljubljana
  • Vesna Zadnik Institute of Oncology Ljubljana
  • Maksimiljan Kadivec Institute of Oncology Ljubljana
Keywords: screening, breast cancer, quality control, screening registry, European guidelines

Abstract

Priporočila za vzpostavitev presejalnih programov za raka dojk je leta 2003 izdala Evropska komisija in države članice Evropske zveze pozvala, da jih organizirajo do leta 2008.


V Sloveniji od leta 2008 deluje Državni program za raka dojk DORA, ki je konec leta 2017 vključeval vse slovenske ženske z ciljne skupine. Ženske v starosti 50–69 let so vsaki dve leti pisno povabljene na presejalni pregled z mamografijo, ki omogoča odkritje še netipnih sprememb v dojki. V primeru sumljivih sprememb na mamografiji so ženske povabljene na nadaljnjo obravnavo, če je odkrit rak dojke, pa tudi na zdravljenje. Od 2018 v okviru programa deluje 21 mamografov v 16 stacionarnih in 3 mobilnih presejalnih enotah, kjer se opravljajo presejalne mamografije, in 2 presejalno-diagnostična centra za nadaljnjo obravnavo žensk in zdravljenje v presejanju odkritih rakov.


Program DORA deluje v skladu z visokimi standardi Evropskih smernic za zagotavljanje kakovosti presejanja za raka dojk in zagotavlja enako obravnavo za vse udeleženke v katerikoli presejalni enoti v Sloveniji. Cilj presejalnega programa je ob vsaj 70-odstotni udeležbi žensk doseči znižanje umrljivosti za rakom dojk v ciljni populaciji za 25–30 %. Letno merjeni kazalniki kakovosti programa kažejo, da je program učinkovit in vodi k omenjenemu cilju.


Posebnosti slovenskega organiziranega programa so: centraliziran populacijski program, vabljenje žensk z vnaprej določenim terminom slikanja, dvojno odčitavanje, konsenz konferenca, nadaljnja obravnava je del presejalnega postopka, multidisciplinarni sestanki, presejalni register z enotno aplikacijo za vnašanje vseh presejalnih korakov – od vabila do mamografij in nadaljnje obravnave, nadzor kakovosti dela radioloških inženirjev in radiologov, stalen strokovni nadzor nad izvajalci programa in letno merjenje kazalnikov kakovosti programa.


Abstract (Eng)

In 2003, European Commission issued recommendations for breast cancer screening programme implementation and called upon member states to establish it untill 2008.


Slovenian national breast cancer screening programme DORA started inviting women in 2008 and finished national implementation in 2017. Women aged 50 to 69 are invited to attend screening mammography every 2 years. Mammography can show clinically occult impalpable breast lesions. In case of positive mammography test, women are invited for further assessment of lesions, and treated in case of a breast cancer diagnosis. Since 2018, screening mammographies are performed on 21 mammographic machines at 16 stationary and in 3 mobile screening centres. Additionally, further assessment and screen-detected cancer treatment take place at two screening and diagnostic centres at the Institute of Oncology Ljubljana and at the Maribor University Medical Centre.


DORA programme follows European guidelines for quality control in screening from the very beginning and provides equal care for all invited women in all DORA screening units throughout Slovenia. The aim of the screening programme is to decrease breast cancer mortality rates in the target population by 25-30%, with precondition of 70% uptake. Slovenian programme effectiveness is proven by acceptable performance indicators' results.


Characteristics of Slovenian organized breast cancer screening are: centralized population-based programme, invitations with prefixed appointment for eligible women, double reading, consensus conference, further assessment is managed by screening programme, multidisciplinary meetings, screening registry with a special computer software for registration of all screening and assessment activities, quality assurance for radiologists and radiographers, regular quality control for programme providers, yearly monitoring of screening performance indicators.

Published
2020-11-06
How to Cite
Jarm, K., Hertl, K., Krajc, M., Šval, C., Kutnar, V., Kurir, M., Primic Žakelj, M., Zadnik, V., & Kadivec, M. (2020). Ten years of the National breast cancer screening programme DORA. Onkologija : A Medical-Scientific Journal, 24(2), 12-22. Retrieved from https://revijaonkologija.si/Onkologija/article/view/447
Section
Original Scientific Article
Page
12-22